Anti-Zika Virus Activity of Plant Extracts Containing Polyphenols and Triterpenes on Vero CCL-81 and Human Neuroblastoma SH-SY5Y Cells.


Journal

Chemistry & biodiversity
ISSN: 1612-1880
Titre abrégé: Chem Biodivers
Pays: Switzerland
ID NLM: 101197449

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 08 11 2021
accepted: 09 03 2022
pubmed: 15 3 2022
medline: 23 4 2022
entrez: 14 3 2022
Statut: ppublish

Résumé

Zika virus (ZIKV) infection is a global threat associated to neurological disorders in adults and microcephaly in children born to infected mothers. No vaccine or drug is available against ZIKV. We herein report the anti-ZIKV activity of 36 plant extracts containing polyphenols and/or triterpenes. ZIKV-infected Vero CCL-81 cells were treated with samples at non-cytotoxic concentrations, determined by MTT and LDH assays. One third of the extracts elicited concentration-dependent anti-ZIKV effect, with viral loads reduction from 0.4 to 3.8 log units. The 12 active extracts were tested on ZIKV-infected SH-SY5Y cells and significant reductions of viral loads (in log units) were induced by Maytenus ilicifolia (4.5 log), Terminalia phaeocarpa (3.7 log), Maytenus rigida (1.7 log) and Echinodorus grandiflorus (1.7 log) extracts. Median cytotoxic concentration (CC

Identifiants

pubmed: 35285139
doi: 10.1002/cbdv.202100842
doi:

Substances chimiques

Plant Extracts 0
Polyphenols 0
Triterpenes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202100842

Subventions

Organisme : UFMG
Organisme : Brazilian agencies CNPq
ID : 421563/2018-4
Organisme : Brazilian agencies CNPq
ID : 440423/2016-13
Organisme : Brazilian agencies CNPq
ID : 425359/2018-2
Organisme : Brazilian agencies CNPq
ID : 421375/2017-5
Organisme : CAPES
ID : 88881.130741
Organisme : FAPEMIG
ID : APQ-02281-18
Organisme : FINEP
ID : 01.16.0050.00
Organisme : ZIKALLIANCE consortium
ID : 734548
Organisme : National Institute of Science and Technology
ID : 465425/2014-3
Organisme : L'Oréal-UNESCO-ABC
Organisme : CAPES
Organisme : CNPq

Informations de copyright

© 2022 Wiley-VHCA AG, Zurich, Switzerland.

Références

F. A. Kurscheidt, C. S. S. Mesquita, G. M. Z. F. Damke, E. Damke, A. R. B. A. Carvalho, T. T. Suehiro, J. J. V. Teixeira, V. R. S. daSilva, R. P. Souza, M. E. L. Consolaro, ‘Persistence and clinical relevance of Zika virus in the male genital tract’, Nat. Rev. Urol. 2019, 16, 211-230.
C. Zanluca, V. C. Melo, A. L. Mosimann, G. I. Santos, C. N. Santos, K. Luz, ‘First report of autochthonous transmission of Zika virus in Brazil’, Mem. Inst. Oswaldo Cruz 2015, 110, 569-572.
https://antigo.saude.gov.br/images/pdf/2020/August/31/Boletim-epidemiologico-SVS-34.pdf; Accessed 23 June 2021.
P. Brasil, J. P. Pereira, Jr., M. E. Moreira, R. M. Ribeiro Nogueira, L. Damasceno, M. Wakimoto, R. S. Rabello, S. G. Valderramos, U. A. Halai, T. S. Salles, A. A. Zin, D. Horovitz, P. Daltro, M. Boechat, C. Raja Gabaglia, P. Carvalho de Sequeira, J. H. Pilotto, R. Medialdea-Carrera, D. Cotrim da Cunha, L. M. Abreu de Carvalho, M. Pone, A. Machado Siqueira, G. A. Calvet, A. E. Rodrigues Baião, E. S. Neves, P. R. Nassar de Carvalho, R. H. Hasue, P. B. Marschik, C. Einspieler, C. Janzen, J. D. Cherry, A. M. Bispo de Filippis, K. Nielsen-Saines, ‘Zika virus infection in pregnant women in Rio de Janeiro’, N. Engl. J. Med. 2016, 375, 2321-2334.
G. Li, S. Bos, K. A. Tsetsarkin, A. G. Pletnev, P. Desprès, G. Gadea, R. Y. Zhao, ‘The roles of prM−E proteins in historical and epidemic Zika virus mediated infection and neurocytotoxicity’, Viruses 2019, 11, 157.
F. Rombi, R. Bayliss, A. Tuplin, S. Yeoh, ‘The journey of zika to the developing brain’, Mol. Biol. Rep. 2020, 47, 3097-3115.
J. P. Martinez, F. Sasse, M. Brönstrup, J. Diez, A. Meyerhans, ‘Antiviral drug discovery: broad-spectrum drugs from nature’, Nat. Prod. Rep. 2015, 32, 29-48.
S. Wichit, N. Gumpangseth, R. Hamel, S. Yainoy, S. Arikit, C. Punsawad, D. Missé, ‘Chikungunya and Zika viruses: Co-circulation and the interplay between viral proteins and host factors’, Pathogens 2021, 10, 448.
R. Bruggisser, K. von Daeniken, G. Jundt, W. Schaffner, H. Tullberg-Reinert, ‘Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay’, Planta Med. 2002, 68, 445-448.
G. Fotakis, J. A. Timbrell, ‘In Vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride’, Toxicol. Lett. 2006, 160, 171-177.
L. G. Verdi, I. M. C. Brighente, M. G. Pizzolatti, ‘Gênero Baccharis (Asteraceae): aspectos químicos, econômicos e biológicos’, Quim. Nova 2005, 28, 85-94.
P. M. Costa, P. M. Ferreira, V. da Silva Bolzani, M. Furlan, V. A. de Freitas Formenton Macedo Dos Santos, J. Corsino, M. O. de Moraes, L. V. Costa-Lotufo, R. C. Montenegro, C. Pessoa, ‘Antiproliferative activity of pristimerin isolated from Maytenus ilicifolia (Celastraceae) in human HL-60 cells’, Toxicol. In Vitro 2008, 22, 854-863.
J. A. Jackman, V. V. Costa, S. Park, A. Real, J. H. Park, P. L. Cardozo, A. R. Ferhan, I. G. Olmo, T. P. Moreira, J. L. Bambirra, V. F. Queiroz, C. M. Queiroz-Junior, G. Foureaux, D. G. Souza, F. M. Ribeiro, B. K. Yoon, E. Wynendaele, B. DeSpiegeleer, M. M. Teixeira, N. J. Cho, ‘Therapeutic treatment of Zika virus infection using a brain-penetrating antiviral peptide’, Nat. Mat. 2018, 17, 971-977.
H. Fortin, C. Vigor, F. Lohézic-LeDévéhat, V. Robin, B. LeBossé, J. Boustie, M. Amoros, ‘In vitro antiviral activity of thirty-six plants from la Réunion Island’, Fitoterapia 2002, 73, 346-350.
L. A. Betancur-Galvis, G. E. Morales, J. E. Forero, J. Roldan, ‘Cytotoxic and antiviral activities of Colombian medicinal plant extracts of the Euphorbia genus’, Mem. Inst. Oswaldo Cruz 2002, 97, 541-546.
R. Sood, R. Raut, P. Tyagi, P. K. Pareek, T. K. Barman, S. Singhal, R. K. Shirumalla, V. Kanoje, R. Subbarayan, R. Rajerethinam, N. Sharma, A. Kanaujia, G. Shukla, Y. K. Gupta, C. K. Katiyar, P. K. Bhatnagar, D. J. Upadhyay, S. Swaminathan, N. Khanna, ‘Cissampelos pareira Linn: natural source of potent antiviral activity against all four Dengue virus serotypes’, PLOS Negl. Trop. Dis. 2015, 9, e0004255.
L. Zhang, M.-Y. Ji, B Qiu, Q.-Y. Li, K.-Y. Zhang, J.-C. Liu, L.-S. Dang, M.-H. Li, ‘Phytochemicals and biological activities of species from the genus Maytenus’, Med. Chem. Res. 2020, 29, 575-606.
E. Clain, J. G. Haddad, A. C. Koishi, L. Sinigaglia, W. Rachidi, P. Desprès, C. N. Duarte dos Santos, P. Guiraud, N. Jouvenet, C. El Kalamouni, ‘The polyphenol-rich extract from Psiloxylon mauritianum, an endemic medicinal plant from Reunion Island, inhibits the early stages of Dengue and Zika virus infection’, Int. J. Mol. Sci. 2020, 19, 1860.
J. G. Haddad, A. C. Koishi, A. Gaudry, C. Nunes Duarte dos Santos, W. Viranaicken, P. Desprès, C. El Kalamouni, ‘Doratoxylon apetalum, an indigenous medicinal plant from mascarene islands, is a potent inhibitor of Zika and Dengue virus infection in human cells’, Int. J. Mol. Sci. 2020, 19, 2382.
J. G. Haddad, D. Grauzdytė, A. C. Koishi, W. Viranaicken, P. R. Venskutonis, D. S. C. Nunes, P. Desprès, N. Diotel, C. El Kalamouni, ‘The geraniin-rich extract from reunion island endemic medicinal plant Phyllanthus phillyreifolius inhibits Zika and Dengue virus infection at non-toxic effect doses in Zebrafish’, Molecules 2020, 25, 2316.
M. Basic, F. Elgner, D. Bender, C. Sabino, M. L. Herrlein, H. Roth, M. Glitscher, A. Fath, T. Kerl, H. G. Schmalz, E. Hildt, ‘A synthetic derivative of houttuynoid B prevents cell entry of Zika virus’, Antiviral Res. 2019, 172, 104644.
G. Wong, S. He, V. Siragam, Y. Bi, M. Mbikay, M. Chretien, X. Qiu, ‘Antiviral activity of quercetin-3-β-O-D-glucoside against Zika virus infection’, Virol. Sin. 2017, 32, 545-547.
A. Gaudry, S. Bos, W. Viranaicken, M. Roche, P. Krejbich-Trotot, G. Gadea, P. Desprès, C. El-Kalamouni, ‘The flavonoid isoquercitrin precludes initiation of Zika virus infection in human cells’, Int. J. Mol. Sci. 2018, 19, 1093.
G. M. Ferreira, B. M. Silva, G. H. B. deSouza, A. B. de Oliveira, G. C. Brandão, ‘Anti-zika activity of Ouratea semiserrata and dereplication of its constituents’, Rev. Bras. Farmacogn. 2021, 31, 121-125.
A. Mohd, N. Zainal, K. K. Tan, S. Abubakar, ‘Resveratrol affects Zika virus replication in vitro’, Sci. Rep. 2019, 9, 14336.
A. H. D. Cataneo, D. Kuczera, A. C. Koishi, C. Zanluca, G. F. Silveira, T. B. Arruda, A. A. Suzukawa, L. O. Bortot, M. Dias-Baruffi, W. A. Verri, Jr., A. W. Robert, M. A. Stimamiglio, C. N. Duarte dos Santos, P. F. Wowk, J. Bordignon, ‘The citrus flavonoid naringenin impairs the in vitro infection of human cells by Zika virus’, Sci. Rep. 2019, 9, 16348.
S. Acquadro, A. Civra, C. Cagliero, A. Marengo, M. Rittà, R. Francese, C. Sanna, C. Bertea, B. Sgorbini, D. Lembo, M. Donalisio, P. Rubiolo, ‘Punica granatum leaf ethanolic extract and ellagic acid as inhibitors of Zika virus infection’, Planta Med. 2020, 86, 1363-1374.
Á. Vázquez-Calvo, N. Jiménez de Oya, M. A. Martín-Acebes, E. Garcia-Moruno, J. C. Saiz, ‘Antiviral properties of the natural polyphenols delphinidin and epigallocatechin gallate against the flaviviruses West Nile virus, Zika virus and Dengue virus’, Front. Microbiol. 2017, 8, 1314.
J. L. Lee, M. Loe, R. Lee, J. Chu, ‘Antiviral activity of pinocembrin against Zika virus replication’, Antiviral Res. 2019, 167, 13-24.
L. S. Abreu, Y. M. do Nascimento, R. Costa, M. Guedes, B. Souza, L. J. Pena, V. C. O. Costa, M. T. Scotti, R. Braz-Filho, J. M. Barbosa-Filho, M. S. Silva, E. S. Velozo, J. F. Tavares, ‘Tri- and diterpenoids from Stillingia loranthacea as inhibitors of Zika virus replication’, J. Nat. Prod. 2019, 82, 2721-2730.
N. Luplertlop, S. Suwanmanee, W. Muangkaew, S. Ampawong, T. Kitisin, Y. Poovorawan, ‘The impact of Zika virus infection on human neuroblastoma (SH-SY5Y) cell lines’, J. Vector Borne Dis. 2017, 54, 207-214.
H. A. Braz-De-Melo, G. Pasquarelli-do-Nascimento, R. Corrêa, R. das Neves Almeida, I. de Oliveira Santos, P. S. Prado, V. Picolo, A. F. Bem, N. Pizato, K. G. Magalhães, ‘Potential neuroprotective and anti-inflammatory effects provided by omega-3 (DHA) against Zika virus infection in human SH-SY5Y cells’, Sci. Rep. 2019, 9, 20119.
C. Sabino, M. Basic, D. Bender, F. Elgner, K. Himmelsbach, E. Hildt, ‘Bafilomycin A1 and U18666 A efficiently impair ZIKV infection’, Viruses 2019, 11, 524.
J. A. Bernatchez, Z. Yang, M. Coste, J. Li, S. Beck, Y. Liu, A. E. Clark, Z. Zhu, L. A. Luna, C. D. Sohl, B. W. Purse, R. Li, J. L. Siqueira-Neto, ‘Development and validation of a phenotypic high-content imaging assay for assessing the antiviral activity of small-molecule inhibitors targeting Zika virus’, Antimicrob. Agents Chemother. 2018, 62, e00725-18.
R. Delvecchio, L. M. Higa, P. Pezzuto, A. L. Valadão, P. P. Garcez, F. L. Monteiro, E. C. Loiola, A. A. Dias, F. J. Silva, M. T. Aliota, E. A. Caine, J. E. Osorio, M. Bellio, D. H. O′Connor, S. Rehen, R. S. de Aguiar, A. Savarino, L. Campanati, A. Tanuri, ‘Chloroquine, an endocytosis blocking agent, inhibits Zika virus infection in different cell models’, Viruses 2016, 8, 322.
B. R. R. Cavalcante, L. S. Aragão-França, G. L. A. Sampaio, C. K. V. Nonaka, M. S. Oliveira, G. S. Campos, S. I. Sardi, B. R. S. Dias, J. P. B. Menezes, V. P. C. Rocha, E. A. Rossi, B. D. Paredes, G. L. S. Martins, K. J. Allahdadi, L. R. Peixoto, J. M. Barbosa-Filho, B. S. F. Souza, M. B. P. Soares, ‘Betulinic acid exerts cytoprotective activity on Zika virus infected neural progenitor cells’, Front. Cell Infect. Microbiol. 2020, 10, 558324.
S. Y. Lyu, J. Y. Rhim, W. B. Park, ‘Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro’, Arch. Pharm. Res. 2005, 28, 1293-1301.
I. G. Bieski, F. RiosSantos, R. M. de Oliveira, M. M. Espinosa, M. Macedo, U. P. Albuquerque, D. T. de Oliveira Martins, ‘Ethnopharmacology of medicinal plants of the pantanal region (Mato Grosso, Brazil)’, Evid. Based Complement. Altern. Med. 2012, 272749.
J. H. S. Gomes, U. C. Mbiakop, R. L. Oliveira, J. R. Stehmann, R. M. Pádua, S. F. Cortes, F. C. Braga, ‘Polyphenol-rich extract and fractions of Terminalia phaeocarpa Eichler possess hypoglycemic effect, reduce the release of cytokines, and inhibit lipase, α-glucosidase, and α-amilase enzymes’, J. Ethnopharmacol. 2021, 271, 113847.
H. Y. Cheng, C. C. Lin, T. C. Lin, ‘Anti-herpes simplex virus type 2 activity of casuarinin from the bark of Terminalia arjuna Linn’, Antiviral Res. 2002, 55, 447-455.
A. Dwevedi, R. Dwivedi, Y. K. Sharma, ‘Exploration of phytochemicals found in Terminalia sp. and their antiretroviral activities’, Pharmacogn. Rev. 2016, 10, 73-83.
R. Niero, S. F. de Andrade, V. Cechinel Filho, ‘A review of the ethnopharmacology, phytochemistry and pharmacology of plants of the Maytenus genus’, Curr. Pharm. Des. 2011, 17, 1851-1871.
R. S. Silveira, G. C. Leal, T. R. D. Molin, H. Faccin, L. A. Gobo, G. D. Silveira, M. T. S. Souza, O. A. Lameira, L. M. Carvalho, C. Viana, ‘Determination of phenolic and triterpenic compounds in Jatropha gossypiifolia L by Ultra-high performance liquid chromatography-tandem mass spectrometric (UHPLC/MS/MS)’, Braz J. Pharm. Sci. 2020, 56, e17262.
C. Gómez-Calderón, C. Mesa-Castro, S. Robledo, S. Gómez, S. Bolivar-Avila, F. Diaz-Castillo, M. Martínez-Gutierrez, ‘Antiviral effect of compounds derived from the seeds of Mammea americana and Tabernaemontana cymosa on Dengue and Chikungunya virus infections’, BMC Complement. Altern. Med. 2017, 17, 57.
M. W. C. Loe, E. Hao, M. Chen, C. Li, R. C. H. Lee, I. X. Y. Zhu, Z. Y. Teo, W. X. Chin, X. Hou, J. Deng, J. J. H. Chu, ‘Betulinic acid exhibits antiviral effects against Dengue virus infection’, Antiviral Res. 2020, 184, 104954.
G. S. Rao, J. E. Sinsheimer, ‘Antiviral activity of triterpenoid saponins containing acylated beta-amyrin aglycones’, J. Pharm. Sci. 1974, 63, 471-473.
P. Bag, D. Chattopadhyay, H. Mukherjee, D. Ojha, N. Mandal, M. C. Sarkar, T. Chatterjee, G. Das, S. Chakraborti, ‘Anti-herpes virus activities of bioactive fraction and isolated pure constituent of Mallotus peltatus: an ethnomedicine from Andaman Islands’, Virol. J. 2012, 9, 98.
M. Hattori, C. M. Ma, Y. Wei, R. Salah El Dine, N. Sato, ‘Survey of anti-HIV and anti-HCV compounds from natural sources’, Can. Chem. Tran. 2013, 1, 116-140.
T. Mosmann, ‘Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays’, J. Immunol. Methods 1983, 65, 55-63.
V. Vichai, K. Kirtikara, ‘Sulforhodamine B colorimetric assay for cytotoxicity screening’, Nat. Protoc. 2006, 1, 1112-1116.

Auteurs

Rosângela Santos Pereira (R)

Department of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, CEP 31270-901, Belo Horizonte, Brazil.

Vivian Vasconcelos Costa (V)

Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, CEP 31270-901, Belo Horizonte, Brazil.
Department of Morphology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, CEP 31270-901, Belo Horizonte, Brazil.

Gabriel Luiz Menezes Gomes (G)

Department of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, CEP 31270-901, Belo Horizonte, Brazil.

Priscilla Rodrigues Valadares Campana (P)

Department of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, CEP 31270-901, Belo Horizonte, Brazil.

Rodrigo Maia de Pádua (R)

Department of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, CEP 31270-901, Belo Horizonte, Brazil.

Milton Barbosa (M)

Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Universidade Federal de Minas Gerais, CEP 31270-901, Belo Horizonte, Brazil.

Yumi Oki (Y)

Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Universidade Federal de Minas Gerais, CEP 31270-901, Belo Horizonte, Brazil.

Gustavo Heiden (G)

Empresa Brasileira de Pesquisa Agropecuária Clima Temperado, CEP 96010-971, Pelotas, Brazil.

Geraldo Wilson Fernandes (GW)

Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Universidade Federal de Minas Gerais, CEP 31270-901, Belo Horizonte, Brazil.

Djalma Menezes de Oliveira (D)

Department of Chemistry, Universidade Estadual do Sudoeste da Bahia, CEP 45208-091, Jequié, Brazil.

Daniele G Souza (DG)

Department of Microbiology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, CEP 31270-901, Belo Horizonte, Brazil.

Mauro Martins Teixeira (M)

Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, CEP 31270-901, Belo Horizonte, Brazil.

Fernão Castro Braga (F)

Department of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Av. Antônio Carlos, 6627, Pampulha, CEP 31270-901, Belo Horizonte, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH